| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0f244c6155c2c1d73694b62b1c889927 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2011-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2278740bb5aded279fd3d843f506df72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0755b49fd8a5a1f4067be0c4d9aa4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfefadd1d716941908555c51893d4a1e |
| publicationDate |
2011-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7947653-B1 |
| titleOfInvention |
Methods for treating epidermal growth factor receptor tyrosine kinase inhibitor-resistant cancers |
| abstract |
Cancer treatment with a combination of an Epidermal Growth Factor Receptor tyrosine kinase inhibitor and an Interleukin-6 inhibitor. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9550828-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10450613-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11672801-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10286070-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10640524-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014002108-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018075823-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11633457-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9890187-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010239656-A1 |
| priorityDate |
2009-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |